ADAPTABLE

Comparing Effectiveness of Two Daily Doses of Aspirin

Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) is a study that compared the effectiveness of two daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease.

Funded through a Patient-Centered Outcomes Research Institute (PCORI) Award, ADAPTABLE spanned the U.S. and was the first demonstration project conducted through PCORnet, the National Patient-Centered Clinical Research Network. PCORnet is a PCORI-funded initiative designed to improve the nation’s capacity to conduct comparative clinical effectiveness research.

CAPriCORN worked with partners in Chicagoland to recruit patients during office visits and in non-clinical settings in underserved communities.

The ADAPTABLE study closed enrollment on July 1, 2019, with more than 15,000th participants. We are currently working on follow-ups for this study.

More Informaton

CAPriCORN Network Partners

Sponsor

Collaborators